共 50 条
- [2] FACTORS INVOLVED IN RESPONSE TO THALIDOMIDE IN MYELODYSPLASTIC SYNDROME: IMPACT OF HLA AND PROGNOSTIC FACTORS HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 406 - 407
- [10] Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients JOURNAL OF BLOOD MEDICINE, 2021, 12 : 1019 - 1030